Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug ...
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...
The Food and Drug Administration (FDA) on Friday declared shortages of three intravenous drugs produced at a North Carolina ...
Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, ...
Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...
The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...
The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling medicines while it reevaluates its recent decision to declare the drugs back in ...
Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...
Eli Lilly has finally made enough supply of its popular medicine tirzepatide to meet soaring demand, which should help the ...
Most of the more than 15 million US adult patients of ADHD taking medication to treat the condition say drug shortages are ...
A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...